Related Experiment Video

Updated: Jun 3, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

MicroRNAs as therapeutic targets in cancer

S Patrick Nana-Sinkam1, Carlo M Croce

  • 1Division of Pulmonary, Allergy, Critical Care and Sleep, The Ohio State University, Columbus, Ohio, USA.

Translational Research : the Journal of Laboratory and Clinical Medicine
|March 23, 2011
PubMed

Insights

MicroRNAs (miRNAs) are key regulators of gene expression fundamental to cancer development. This review explores their role in malignancies and potential as cancer biomarkers and therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Cancer is a global health challenge requiring novel therapeutic strategies.
  • MicroRNAs (miRNAs) represent a significant layer of gene regulation impacting cellular functions.
  • miRNA dysregulation is implicated in the pathogenesis of various cancers.

Purpose of the Study:

  • To review the current understanding of miRNA roles in solid and hematological malignancies.
  • To highlight the potential of miRNAs as prognostic biomarkers and therapeutic targets in cancer treatment.

Main Methods:

  • Literature review of scientific publications on miRNAs in cancer.
  • Analysis of miRNA involvement in molecular pathogenesis of diverse cancer types.
  • Focus on clinical translation of miRNA-based cancer therapies.

Main Results:

  • miRNAs regulate fundamental cellular processes crucial for cancer development.
  • Dysregulated miRNAs are implicated in both solid tumors and hematological malignancies.
  • miRNAs' ability to target multiple genes makes them promising biomarkers and therapeutic targets.

Conclusions:

  • MicroRNAs are integral to cancer pathogenesis and progression.
  • Further research into miRNAs offers significant potential for developing novel cancer diagnostics and therapeutics.
  • Overcoming challenges in miRNA clinical translation is essential for realizing their full therapeutic promise.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...